Oldest pages

Jump to navigation Jump to search

Showing below up to 50 results in range #4,151 to #4,200.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Vanhaesebroeck B, et al. Nat. Rev. Mol. Cell. Biol. (2010) cited as Ref 353 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  2. Wang Q, et al. Br. J. Cancer (2017) cited as Ref 354 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  3. Loewith R, et al. Mol. Cell (2002) cited as Ref 355 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  4. Kim DH, et al. Cell (2002) cited as Ref 356 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  5. Sancak Y, et al. Mol. Cell (2007) cited as Ref 357 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  6. Knowles MA, et al. Cancer metastasis Rev. (2009) cited as Ref 358 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  7. Duan S, et al. Nat. Commun. (2015) cited as Ref 359 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  8. Yuzugullu H, et al. Nat. Commun. (2015) cited as Ref 360 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  9. Fumarola C, et al. Biochem. Pharmacol. (2014) cited as Ref 361 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  10. Dey N, et al. Pharmacol. Ther. (2017) cited as Ref 362 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  11. Offermann A, et al. Oncotarget (2017) cited as Ref 363 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  12. Giulino-Roth L, et al. Mol. cancer therapeutics (2017) cited as Ref 364 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  13. Zaidi AH, et al. Ann. Surg. (2017) cited as Ref 365 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  14. Karki R, et al. Cell Cycle (2017) cited as Ref 366 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  15. Deng J, et al. BMC Cancer (2019) cited as Ref 367 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  16. Chang L, et al. Cell death Dis. (2013) cited as Ref 368 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  17. Fitzgerald TL, et al. Adv. Biol. Regul. (2015) cited as Ref 369 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  18. Dubrovska A, et al. Proc. Natl Acad. Sci. USA (2009) cited as Ref 370 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  19. , et al. () cited as Ref 371 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  20. Yang C, et al. Int. J. Oncol. (2015) cited as Ref 372 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  21. Huang EH, et al. Cancer Res. (2009) cited as Ref 373 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  22. Nishitani S, et al. PLoS ONE (2013) cited as Ref 374 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  23. Karki R, et al. Nature (2016) cited as Ref 375 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  24. Chen WJ, et al. J. Nutr. Biochem. (2017) cited as Ref 376 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  25. Bonuccelli G, et al. Aging (Albany, NY) (2018) cited as Ref 377 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  26. Issemann I, et al. Nature (1990) cited as Ref 378 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  27. Peters JM, et al. Nat. Rev. Cancer (2012) cited as Ref 379 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  28. Kuenzli S, et al. Br. J. Dermatol. (2003) cited as Ref 380 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  29. Elbrecht A, et al. Biochem. Biophys. Res. Commun. (1996) cited as Ref 381 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  30. Tyagi S, et al. J. Adv. Pharm. Technol. Res. (2011) cited as Ref 382 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  31. Sertznig P, et al. Dermatol. Endocrinol. (2011) cited as Ref 383 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  32. Houseknecht KL, et al. Domest. Anim. Endocrinol. (2002) cited as Ref 384 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  33. Yousefnia S, et al. Gene (2018) cited as Ref 385 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  34. Kramer K, et al. Oncogene (2016) cited as Ref 386 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  35. Wang Y, et al. Int. J. Mol. Med. (2014) cited as Ref 387 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  36. Basu-Roy U, et al. Oncotarget (2016) cited as Ref 388 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  37. Giampietri Claudia, et al. International Journal of Molecular Sciences (2017) cited as Ref 389 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  38. Deng X, et al. Int. J. Mol. Med. (2015) cited as Ref 390 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  39. Bigoni-Ordonez GD, et al. BMC Cancer (2018) cited as Ref 391 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  40. Liu L, et al. PLoS ONE (2013) cited as Ref 392 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  41. Rinaldi L, et al. eLife (2017) cited as Ref 393 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  42. Wang H, et al. Chin. J. Lung Cancer (2014) cited as Ref 394 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  43. Lebleu VS, et al. Nat. Cell Biol. (2014) cited as Ref 395 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  44. Wang X, et al. Dev. Cell. (2019) cited as Ref 396 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  45. Kim JH, et al. Sci. Rep. (2018) cited as Ref 397 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  46. Maehara O, et al. Neoplasia (2019) cited as Ref 398 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  47. Katoh M, et al. Stem Cell Rev. (2007) cited as Ref 399 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  48. Schon S, et al. Int. J. Cancer (2014) cited as Ref 400 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  49. Liu D, et al. Oncotarget (2016) cited as Ref 401 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)
  50. Du Q, et al. Cancer Res. (2009) cited as Ref 402 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:06, 20 May 2020)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)